NEWOMICS INC.
Emeryville, CA · CIK 0001827643 · Medtech · Private
Nanoflow LC-picoelectrospray ionization mass spectrometry system with microfabricated multinozzle emitters for top-down proteomics analysis
newomics.com →- Grants
- $17M
- 20 awards
- Sector median: 1
- Raised
- $3.9M
- 1 Form D · Oct 2020
- 71 months since last filing
- Contracts
- $330K
- 2 awards · Health and Human S
- #415 of 4531 in medtech
- Patents
- 15
- 3 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Omics-chips For Ctc Isolation And Molecular Analysis | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Microfluidic Chips for Biomonitoring | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase I · AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease | $349,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics | $341,623 | |
| Federal grant | Department of Health and Human Services · Phase I · Senescence-Chips for Radiation Biodosimetry | $299,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Microfluidic Chips for Biomonitoring | $746,462 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultrahigh-throughput Identification of Molecular Targets of Natural Products | $688,748 | |
| Federal grant | Department of Health and Human Services · Phase II · Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultrahigh-throughput Identification of Molecular Targets of Natural Products | $811,252 | |
| Federal grant | Department of Health and Human Services · Phase II · Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells | $2,500 | |
| Federal grant | Department of Health and Human Services · Phase II · AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease | $749,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Senescence-Chips for Radiation Biodosimetry | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Senescence-Chips for Radiation Biodosimetry | $2,994,730 | |
| Federal grant | Department of Health and Human Services · Phase II · AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease | $749,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Senescence-Chips for Radiation Biodosimetry | $997,365 | |
| Private capital raised | Form D · SEC | $3,924,995 | |
| Federal grant | Department of Health and Human Services · Phase II · Senescence-Chips for Radiation Biodosimetry | $997,365 | |
| Federal grant | Department of Health and Human Services · Phase II · Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics | $865,365 | |
| Federal grant | Department of Health and Human Services · Phase II · Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics | $1,730,730 | |
| Federal grant | Department of Health and Human Services · Phase II · Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics | $865,365 | |
| Federal contract | Department of Health and Human Services · Electrospray Ionization Source That Will Increase Ionization Efficiency | $30,286 | |
| Federal grant | Department of Health and Human Services · Phase II · Multispray Technology for Studying Biomolecular Interactions | $1,000,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 412 | TELE-STETHOSCOPE INC. | $338K | — |
| 413 | CLARIX IMAGING CORP | $336K | — |
| 414 | AIDAR HEALTH, INC | $336K | — |
| 415 | NEWOMICS INC. | $330K | $3.9M |
| 416 | INSIGHTEC LTD | $309K | $300M |
| 417 | AEROPHASE, INC. | $304K | — |
| 418 | CORGENIX MEDICAL CORPORATION | $301K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ted HouDirector
- Pan MaoDirector
- Patrick ScannonDirector
- Daojing WangDirector · Executive Officer
Patents
- Methods And Systems For Sorting Biological Particlesapplication
- Method For Diagnosing Diseasesapplication
- Methods And Systems For Sorting Biological Particlesapplication
- Methods And Systems For Diagnosing Diseasesgranted
- Methods And Systems For Separating Biological Particlesapplication
- Methods And Systems For Biomonitoringgranted
- Methods And Systems For Diagnosing Diseasesgranted
- Methods And Systems For Diagnosing Diseasesapplication
- Methods And Systems For Sorting Biological Particlesapplication
- Methods And Systems For Separating Biological Particlesapplication
- Methods And Systems For Cell-based Diagnosis And Therapiesapplication
- Methods And Systems For Biomonitoringapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.